Epidemiology of rosacea in Colombia

Prevalence of rosacea has been estimated around the world in the range of 0–22%. In Colombia, the prevalence of rosacea remains unknown. The aim of this study was to determine the prevalence of rosacea and the frequencies of its subtypes in Colombia. This cross‐sectional, multicenter study was condu...

Full description

Autores:
Rueda Jaime, Lili Johana
Motta Beltrán, Adriana
Pabón, Juan G.
Barona, Maria I.
Meléndez, Esperanza
Orozco, Beatriz
Rojas, Ricardo F.
Tipo de recurso:
https://purl.org/coar/resource_type/c_6501
Fecha de publicación:
2020
Institución:
Universidad El Bosque
Repositorio:
Repositorio U. El Bosque
Idioma:
eng
OAI Identifier:
oai:repositorio.unbosque.edu.co:20.500.12495/5106
Acceso en línea:
https://hdl.handle.net/20.500.12495/5106
https://doi.org/10.1111/ijd.13491
Palabra clave:
Epidemiología
Rosácea
Estudios de evaluación como asunto
Rights
License
Acceso abierto
id UNBOSQUE2_318b7b3a5404e05ee8b818fd9f876ca1
oai_identifier_str oai:repositorio.unbosque.edu.co:20.500.12495/5106
network_acronym_str UNBOSQUE2
network_name_str Repositorio U. El Bosque
repository_id_str
dc.title.spa.fl_str_mv Epidemiology of rosacea in Colombia
dc.title.translated.spa.fl_str_mv Epidemiology of rosacea in Colombia
title Epidemiology of rosacea in Colombia
spellingShingle Epidemiology of rosacea in Colombia
Epidemiología
Rosácea
Estudios de evaluación como asunto
title_short Epidemiology of rosacea in Colombia
title_full Epidemiology of rosacea in Colombia
title_fullStr Epidemiology of rosacea in Colombia
title_full_unstemmed Epidemiology of rosacea in Colombia
title_sort Epidemiology of rosacea in Colombia
dc.creator.fl_str_mv Rueda Jaime, Lili Johana
Motta Beltrán, Adriana
Pabón, Juan G.
Barona, Maria I.
Meléndez, Esperanza
Orozco, Beatriz
Rojas, Ricardo F.
dc.contributor.author.none.fl_str_mv Rueda Jaime, Lili Johana
Motta Beltrán, Adriana
Pabón, Juan G.
Barona, Maria I.
Meléndez, Esperanza
Orozco, Beatriz
Rojas, Ricardo F.
dc.contributor.orcid.none.fl_str_mv Motta, Adriana [0000-0002-1924-1256]
Motta Beltrán, Adriana [0000-0002-1924-1256]
Rueda Jaime, Lili Johana [0000-0003-3261-5299]
Motta Beltrán, Adriana [0000-0002-1924-1256]
Rueda Jaime, Lili Johana [0000-0003-3261-5299]
dc.subject.armarc.spa.fl_str_mv Epidemiología
Rosácea
Estudios de evaluación como asunto
topic Epidemiología
Rosácea
Estudios de evaluación como asunto
description Prevalence of rosacea has been estimated around the world in the range of 0–22%. In Colombia, the prevalence of rosacea remains unknown. The aim of this study was to determine the prevalence of rosacea and the frequencies of its subtypes in Colombia. This cross‐sectional, multicenter study was conducted in six outpatient dermatology clinics across Colombia. A total of 33 dermatologists conducted a comprehensive medical history and physical examination for all rosacea patients seen at their offices over the course of 2 months. All patients who accepted to participate were encouraged to answer a survey about the history of their illness. Of 10,204 outpatients evaluated for rosacea between July and August 2014, 291 rosacea patients were included in this study. The prevalence of rosacea subtypes in this cohort was: 45.3% erythematotelangiectatic (ETR) (n = 132), 48.7% papulopustular (PPR) (n = 142), 4.8% phymatous (n = 14), and 1% ocular (n = 3). Overall, the prevalence in Colombia was 2.85%. Our data represent an important first step to understanding the current state of rosacea in Colombia. The prevalence of rosacea in Colombia is the highest in Latin America among a few reports published, which might be explained by geographic features. However, contrary to our expectations, the prevalence is lower than that in some European countries. We postulate that this finding may be due to methodological differences.
publishDate 2020
dc.date.accessioned.none.fl_str_mv 2020-11-20T20:09:13Z
dc.date.available.none.fl_str_mv 2020-11-20T20:09:13Z
dc.date.issued.none.fl_str_mv 2020
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.local.none.fl_str_mv Artículo de revista
dc.type.coar.none.fl_str_mv https://purl.org/coar/resource_type/c_6501
dc.type.driver.none.fl_str_mv info:eu-repo/semantics/article
format https://purl.org/coar/resource_type/c_6501
dc.identifier.issn.none.fl_str_mv 1365-4632
dc.identifier.uri.none.fl_str_mv https://hdl.handle.net/20.500.12495/5106
dc.identifier.doi.none.fl_str_mv https://doi.org/10.1111/ijd.13491
dc.identifier.instname.spa.fl_str_mv instname:Universidad El Bosque
dc.identifier.reponame.spa.fl_str_mv reponame:Repositorio Institucional Universidad El Bosque
dc.identifier.repourl.none.fl_str_mv repourl:https://repositorio.unbosque.edu.co
identifier_str_mv 1365-4632
instname:Universidad El Bosque
reponame:Repositorio Institucional Universidad El Bosque
repourl:https://repositorio.unbosque.edu.co
url https://hdl.handle.net/20.500.12495/5106
https://doi.org/10.1111/ijd.13491
dc.language.iso.none.fl_str_mv eng
language eng
dc.relation.ispartofseries.spa.fl_str_mv International Journal of Dermatology, 1365-4632, Vol. 56, No. 5, 2017, p. 510-513
dc.relation.uri.none.fl_str_mv https://onlinelibrary.wiley.com/doi/abs/10.1111/ijd.13491
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.local.spa.fl_str_mv Acceso abierto
dc.rights.accessrights.none.fl_str_mv https://purl.org/coar/access_right/c_abf2
Acceso abierto
dc.rights.creativecommons.none.fl_str_mv 2017
rights_invalid_str_mv Acceso abierto
https://purl.org/coar/access_right/c_abf2
2017
http://purl.org/coar/access_right/c_abf2
dc.format.mimetype.none.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Springer Link
dc.publisher.journal.spa.fl_str_mv International Journal of Dermatology
institution Universidad El Bosque
bitstream.url.fl_str_mv https://pruebas-update-repositorio-unbosque.cloudbiteca.com/bitstreams/d314e867-a675-4598-8298-193fce550068/download
bitstream.checksum.fl_str_mv 8a4605be74aa9ea9d79846c1fba20a33
bitstream.checksumAlgorithm.fl_str_mv MD5
repository.name.fl_str_mv Repositorio Institucional Universidad El Bosque
repository.mail.fl_str_mv bibliotecas@biteca.com
_version_ 1849967227664596992
spelling Rueda Jaime, Lili JohanaMotta Beltrán, AdrianaPabón, Juan G.Barona, Maria I.Meléndez, EsperanzaOrozco, BeatrizRojas, Ricardo F.Motta, Adriana [0000-0002-1924-1256]Motta Beltrán, Adriana [0000-0002-1924-1256]Rueda Jaime, Lili Johana [0000-0003-3261-5299]Motta Beltrán, Adriana [0000-0002-1924-1256]Rueda Jaime, Lili Johana [0000-0003-3261-5299]2020-11-20T20:09:13Z2020-11-20T20:09:13Z20201365-4632https://hdl.handle.net/20.500.12495/5106https://doi.org/10.1111/ijd.13491instname:Universidad El Bosquereponame:Repositorio Institucional Universidad El Bosquerepourl:https://repositorio.unbosque.edu.coapplication/pdfengSpringer LinkInternational Journal of DermatologyInternational Journal of Dermatology, 1365-4632, Vol. 56, No. 5, 2017, p. 510-513https://onlinelibrary.wiley.com/doi/abs/10.1111/ijd.13491Epidemiology of rosacea in ColombiaEpidemiology of rosacea in ColombiaArtículo de revistahttps://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1info:eu-repo/semantics/articlehttp://purl.org/coar/version/c_970fb48d4fbd8a85EpidemiologíaRosáceaEstudios de evaluación como asuntoPrevalence of rosacea has been estimated around the world in the range of 0–22%. In Colombia, the prevalence of rosacea remains unknown. The aim of this study was to determine the prevalence of rosacea and the frequencies of its subtypes in Colombia. This cross‐sectional, multicenter study was conducted in six outpatient dermatology clinics across Colombia. A total of 33 dermatologists conducted a comprehensive medical history and physical examination for all rosacea patients seen at their offices over the course of 2 months. All patients who accepted to participate were encouraged to answer a survey about the history of their illness. Of 10,204 outpatients evaluated for rosacea between July and August 2014, 291 rosacea patients were included in this study. The prevalence of rosacea subtypes in this cohort was: 45.3% erythematotelangiectatic (ETR) (n = 132), 48.7% papulopustular (PPR) (n = 142), 4.8% phymatous (n = 14), and 1% ocular (n = 3). Overall, the prevalence in Colombia was 2.85%. Our data represent an important first step to understanding the current state of rosacea in Colombia. The prevalence of rosacea in Colombia is the highest in Latin America among a few reports published, which might be explained by geographic features. However, contrary to our expectations, the prevalence is lower than that in some European countries. We postulate that this finding may be due to methodological differences.Acceso abiertohttps://purl.org/coar/access_right/c_abf2Acceso abierto2017http://purl.org/coar/access_right/c_abf2LICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://pruebas-update-repositorio-unbosque.cloudbiteca.com/bitstreams/d314e867-a675-4598-8298-193fce550068/download8a4605be74aa9ea9d79846c1fba20a33MD52falseAnonymousREAD20.500.12495/5106oai:pruebas-update-repositorio-unbosque.cloudbiteca.com:20.500.12495/51062022-05-06T23:44:29.994Zmetadata.onlyhttps://pruebas-update-repositorio-unbosque.cloudbiteca.comRepositorio Institucional Universidad El Bosquebibliotecas@biteca.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